Funded Health Care Startups in Bengaluru
Among the 16 most recent Bengaluru health care financings shown, the largest disclosed round is Primus at $20M (2024-10-16), which stands far above the res…
Among the 16 most recent Bengaluru health care financings shown, the largest disclosed round is Primus at $20M (2024-10-16), which stands far above the rest of the disclosed amounts: outside Primus, only two entries reach $7M+ (Dozee at $7M on 2025-03-25 and Akna Medical at $7M on 2020-04-06), while most other disclosed rounds cluster below $2M. Stage and disclosure are also uneven: five of the 16 rows are tagged “Series Unknown” ($7M for Dozee on 2025-03-25; $5M for Sugar.fit on 2024-03-13; undisclosed for Syook on 2023-10-11; plus two unlabeled rows), and one entry is “undisclosed” (Syook, 2023-10-11).
Temporally, the dataset spans 2020-04-06 (Akna Medical) through 2025-07-09 (Wellopia), with 5 of the 16 rounds occurring from 2025-03-12 to 2025-07-09, including Seed rounds such as Allo Health ($2M, 2025-03-12) and Wellopia ($930K, 2025-07-09). Geographically, every row lists Bengaluru, Karnataka, India, so differences show up in funding size and stage labeling rather than location.
Most recent rounds
16 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Bengaluru health care list, and how does it compare to other disclosed amounts?
Primus leads with $20M on 2024-10-16, dwarfing the next-largest disclosed rounds: Dozee’s $7M (2025-03-25) and Akna Medical’s $7M (2020-04-06). Beyond those, most disclosed rounds sit below $2M (for example, Janitri at $1M on 2025-06-07 and Wellopia at $930K on 2025-07-09).
Do the most recent rounds cluster into a narrow window of time?
Yes. Five of the 16 entries fall between 2025-03-12 and 2025-07-09, including Allo Health ($2M, 2025-03-12), Dozee ($7M, 2025-03-25), Stance Health ($1M, 2025-04-02), Janitri ($1M, 2025-06-07), and Wellopia ($930K, 2025-07-09).
How much of the list has unclear stage labeling (Series Unknown or undisclosed), and which companies drive that?
Five of 16 rows are tagged “Series Unknown” or similarly unlabeled, and one is explicitly “undisclosed.” Dozee ($7M, 2025-03-25) and Sugar.fit ($5M, 2024-03-13) are “Series Unknown,” Syook (2023-10-11) is “undisclosed,” and two rows have blank stage fields (Sugar.fit’s $5M is listed with a blank stage in the table, and Akna Medical at $7M on 2020-04-06 also shows a blank stage).
Which stage labels are most common among the disclosed rounds?
Seed appears repeatedly: Wellopia (Seed, $930K, 2025-07-09), Janitri (Seed, $1M, 2025-06-07 is labeled Seed), Allo Health (Seed, $2M, 2025-03-12), Lifetime Health (Seed, $900K, 2024-05-24), PlatinumRx (Seed, $790K, 2024-04-08), SkinQ (Seed, $360K, 2023-12-28), and Bonatra (Pre-Seed, $670K, 2022-11-21; plus other Seed entries like Yostra Labs at $510K, 2022-08-16). Pre-Seed and named later stages also show up, but Seed is the most consistently recurring label in this slice.
Are there outliers worth flagging by funding size within the timeline?
Two size outliers stand out alongside Primus ($20M, 2024-10-16): Dozee at $7M (2025-03-25) and Akna Medical at $7M (2020-04-06). The smallest disclosed amount is SkinQ at $360K on 2023-12-28, which is materially below the broader middle of the distribution (for example, $670K at Bonatra on 2022-11-21 and $510K at Yostra Labs on 2022-08-16).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.